Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
By D. Del Rio, A. Rodriguez-Mateos, J. Spencer, Massimiliano Tognolini, G. Borges, A. Crozier. Antioxidants and Redox Signaling, 2013
2,403 citations recorded by the source corpus.
Human intervention trials have provided evidence for protective effects of various (poly)phenol-rich foods against chronic disease, including cardiovascular disease, neurodegeneration, and cancer. While there are considerable data suggesting benefits of (poly)phenol intake, conclusions regarding their preventive potential remain unresolved due to several limitations in existing studies. Bioactivity investigations using cell lines have made an extensive use of both (poly)phenolic aglycones and sugar conjugates, these being the typical forms that exist in planta, at concentrations in the low-μM-to-mM range. However, after ingestion, dietary (poly)phenolics appear in the circulatory system not as the parent compounds, but as phase II metabolites, and their presence in plasma after dietary intake rarely exceeds nM concentrations. Substantial quantities of both the parent compounds and their metabolites pass to the colon where they are degraded by the action of the local microbiota, giving rise principally to small phenolic acid and aromatic catabolites that are absorbed into the circulatory system. This comprehensive review describes the different groups of compounds that have been reported to be involved in human nutrition, their fate in the body as they pass through the gastrointestinal tract and are absorbed into the circulatory system, the evidence of their impact on human chronic diseases, and the possible mechanisms of action through which (poly)phenol metabolites and catabolites may exert these protective actions. It is concluded that better performed in vivo intervention and in vitro mechanistic studies are needed to fully understand how these molecules interact with human physiological and pathological processes. Antioxid. Redox Signal. 18, 1818–1892. I. Introduction II. Classification of Phenolic Compounds A. Flavonoids 1. Flavonols 2. Flavones 3. Isoflavones 4. Flavanones 5. Anthocyanidins 6. Flavan-3-ols 7. Dihydrochalcones B. Nonflavonoids III. Bioavailability of Flavonoids and Related Compounds A. Flavonols and flavanones B. Anthocyanins C. Flavones D. Isoflavones E. Flavan-3-ols 1. Cocoa flavan-3-ol monomers 2. Green tea flavan-3-ol monomers a. Dose effects b. Colonic catabolism of green tea flavan-3-ols c. Identification and quantification of flavan-3-ol metabolites 3. Black tea theaflavins and thearubigins F. Proanthocyanidins G. Dihydrochalcones H. Ellagitannins I. Chlorogenic acids J. Resveratrol K. Plant lignans IV. Evidence for the Accumulation of (Poly)phenol Metabolites in Body Tissues V. In Vitro Biological Activity and Mode of Action A. Anthocyanins B. Chlorogenic acids C. Ellagitannins D. Flavan-3-ols E. Flavonols F. Lignans and isoflavones G. Flavanones VI. Feeding Studies and Evidence of Protective Effects A. Cardiovascular effects of dietary polyphenols 1. Cocoa 2. Red wine 3. Tea 4. Berries 5. Pomegranate 6. Citrus fruit 7. Coffee 8. Nuts B. (Poly)phenols and neurodegenerative diseases C. (Poly)phenols and cancer VII. Conclusions
Subfields: Biochemistry, Complementary and alternative medicine
View Paper: https://www.semanticscholar.org/paper/118c330df43317a710def2cf4ee857794e4de1e2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Eunkyoung Kim
- Yuan Xiong
- C. Martínez-Villaluenga
- E. Peñas
- Yi Cheng
- Hsuan-Chen Wu
- Yi Liu
- J. Frías
Citations in the corpus
- Chitosan to Connect Biology to Electronics: Fabricating the Bio-Device Interface and Communicating Across This Interface (2014, background): “, antioxidant) activities of dietary phenols [211,212] attract the most attention, there have been reports of phenolics as potential electronic materials [213–215].”
- Phenolic Compounds in Honey and Their Associated Health Benefits: A Review (2018, background): “In addition to these metabolic biotransformations that affect the absorption, the bioavailability and the distribution of flavonoids at the cellular and tissue levels are also mediated by some proteins that are associated with multi-resistance (MRP1, MRP2), which are part of the third phase of the m”
- Phytochemical evaluation of white (Morus alba L.) and black (Morus nigra L.) mulberry fruits, a starting point for the assessment of their beneficial properties (2015, background): “From health promoting point of view, chlorogenic acids have been recognized by their wide biological properties and have been linked with the healthpromoting features of coffee (Del Rio et al., 2013).”
- Effect of germination and elicitation on phenolic composition and bioactivity of kidney beans (2015, background): “Besides antioxidant activity, in vitro and animal studies have shown that phenolic compounds may exhibit other positive effects such as anti-inflammatory, anti-hypertensive, anti-atherosclerotic and cytotoxic antitumor activities (del Rio et al., 2013).”